PI3K and mTOR inhibitors—a new generation of targeted anticancer agents
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference40 articles.
1. Why is cancer drug discovery so difficult?;Kamb;Nat Rev,2007
2. The PTEN/PI3K/Akt signalling pathway in cancer, therapeutic implications;Carnero;Curr Cancer Drug Targets,2008
3. Class IA PI3 kinase: from their biological implication in human cancers to drug discovery;Maira;Expert Opin Ther Targets,2008
4. Targeting the PI3K–Akt–mTOR pathway: progress, pitfalls, and promises;Yap;Curr Opin Pharmacology,2008
5. Drug discovery approaches targeting the PI3K/Akt pathway in cancer;Garcia-Echeverria;Oncogene,2008
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies;Current Cancer Drug Targets;2024-03
2. Rapamycin and rapalogs for tuberous sclerosis complex;Cochrane Database of Systematic Reviews;2023-07-11
3. Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss;Bioorganic & Medicinal Chemistry;2023-01
4. NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2);Cells;2022-11-22
5. LRBA balances antigen presentation and T-cell responses by facilitating autophagy through the binding to PIK3R4 and FYCO1;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3